As of 2026-03-15, the Relative Valuation of Denali Therapeutics Inc (DNLI) is (79.96) USD. This relative valuation is based on P/E multiples. With the latest stock price at 20.57 USD, the upside of Denali Therapeutics Inc based on Relative Valuation is -488.7%.
The range of the Relative Valuation is (75.35) - (87.72) USD.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| Trailing P/E multiples | 22.9x - 28.3x | 25.6x |
| Forward P/E multiples | 22.2x - 26.7x | 23.0x |
| Fair Price | (75.35) - (87.72) | (79.96) |
| Upside | -466.3% - -526.5% | -488.7% |
| Date | P/E |